STAAR Surgical Company
STAA
$26.30
$0.271.04%
NASDAQ
| 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | |
|---|---|---|---|---|---|
| Revenue | -32.42% | -32.59% | -14.44% | -2.64% | 10.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -32.42% | -32.59% | -14.44% | -2.64% | 10.01% |
| Cost of Revenue | -16.95% | -8.13% | 3.51% | 6.53% | 5.97% |
| Gross Profit | -36.60% | -38.99% | -19.35% | -5.17% | 11.15% |
| SG&A Expenses | -2.65% | 3.13% | 9.53% | 13.36% | 7.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.56% | 0.29% | 7.41% | 11.46% | 7.84% |
| Operating Income | -329.11% | -391.31% | -281.88% | -141.57% | 42.89% |
| Income Before Tax | -362.54% | -441.08% | -329.12% | -126.86% | 35.03% |
| Income Tax Expenses | -66.61% | -119.22% | -14.95% | -9.66% | 137.28% |
| Earnings from Continuing Operations | -542.54% | -673.47% | -564.64% | -194.66% | 6.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -542.54% | -673.47% | -564.64% | -194.66% | 6.99% |
| EBIT | -329.11% | -391.31% | -281.88% | -141.57% | 42.89% |
| EBITDA | -263.19% | -319.40% | -223.23% | -115.67% | 35.35% |
| EPS Basic | -540.46% | -667.84% | -557.42% | -193.33% | 5.42% |
| Normalized Basic EPS | -258.82% | -329.80% | -235.25% | -125.36% | 36.98% |
| EPS Diluted | -545.61% | -672.43% | -569.09% | -196.92% | 9.94% |
| Normalized Diluted EPS | -261.90% | -333.18% | -238.31% | -126.56% | 38.36% |
| Average Basic Shares Outstanding | 0.87% | 0.96% | 1.12% | 1.24% | 1.33% |
| Average Diluted Shares Outstanding | 0.50% | 0.27% | 0.57% | 0.04% | -0.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |